Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-23

Clinical Trial Update: Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer

View source ↗

Summary

An AstraZeneca-sponsored trial update on reasons for changing hormonal therapy in advanced breast cancer has completed. It outlines factors that influence switc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED